胃肠道癌症中的SALL4:上游和下游的调节机制
Tairan Wang1, Yan Jin1, Mengyao Wang2
1School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, 453003, China.
Molecular medicine (Cambridge, Mass.)
|April 7, 2024
概括
一种干细胞因子SALL4在胃肠道 (GIT) 癌症中过度表达,导致瘤发生. 针对与SALL4相关的途径可能为这些具有挑战性的癌症提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- 胃肠道 (GIT) 癌症在有效治疗和早期诊断方面存在重大挑战.
- 胚胎发育中的关键转录因子SALL4,调节细胞增殖,存活,迁移和干细胞功能.
- 过度表达SALL4与瘤发生有关,但其在GIT癌症中的特定作用和机制在很大程度上仍未被阐明.
研究的目的:
- 为了阐明SALL4在各种胃肠道癌症中的功能.
- 在GIT癌症的背景下,识别由SALL4调节的上游/下游基因和信号通路.
- 探索针对SALL4相关基因或向GIT癌症新型治疗干预的途径的潜力.
主要方法:
- 文献综述和对SALL现有研究的分析4.
- 检查SALL4在细胞增殖,存活,迁移和干性中的作用.
- 讨论涉及SALL4驱动的GIT瘤发生的上游/下游分子标和信号通路.
主要成果:
- 在胃肠道癌症的发展和进展中,SALL4发挥着重要作用.
- 过度表达SALL4与瘤发生和癌症相关的细胞功能改变有关.
- 已经确定了在不同的GIT癌症中受到SALL4影响的特定基因和途径.
结论:
- SALL4被认为是胃肠道癌症的一个关键因素.
- 了解SALL4的监管网络,可以了解GIT癌症机制.
- 准SALL4或其相关途径为开发新型GIT癌症疗法提供了一个有希望的途径.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
424
12:14CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
2.6K
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Pleiotropy
40.4K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
